20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T39314 | JAK1/TYK2-IN-1 | JAK1/TYK2-IN-1 | |
JAK1/TYK2-IN-1 is a dual inhibitor of TYK2 and JAK1 ( IC 50 = 29 and 41 nM respectively). | |||
T13237L | Ropsacitinib | Tyk2-IN-8,PF-06826647 | Tyrosine Kinases |
Ropsacitinib (PF-06826647) is a selective TYK2 inhibitor, which binds to TYK2 catalytically active JH1 domain (IC50: 17 nM). | |||
T13232 | TyK2-IN-2 | PDE | |
TyK2-IN-2 is a selective inhibitor of TYK2 (IC50s: 7 nM, 0.1 μM, and 0.05 μM for TYK2 JH2, IL-23, and IFNα). | |||
T13234 | Tyk2-IN-5 | Others | |
Tyk2-IN-5 is a selective and orally active inhibitor of Tyk2 JH2 (Ki: 0.086 nM for Tyk2 JH2; IC50: 25 nM for IFNα). | |||
T13237 | Tyk2-IN-9 | Others | |
Tyk2-IN-9 (Compound 26), a selective Tyk-2 inhibitor, exhibits IC50 values of 0.076 nM for TYK2-JH2 and 1.8 nM for JAK1-JH2, respectively. This specificity makes it suitable for research into inflammatory or autoimmune d... | |||
T13233 | Tyk2-IN-3 | Tyrosine Kinases | |
Tyk2-IN-3 is an inhibitor of Tyk2 pseudokinase (IC50: 485 nM). | |||
T13235 | Tyk2-IN-7 | Others | |
Tyk2-IN-7 is an inhibitor of TYK2 JH2, binds to the TYK2 JH2 domain (IC50: 0.00053 μM; Ki.app: 0.00007 μM). | |||
T62451 | TYK2-IN-12 | ||
TYK2-IN-12 (compound 30) is a selective, orally active inhibitor of TYK2 (tyrosine kinase 2) (Ki: 0.51 nM). TYK2-IN-12 inhibits IL-12-induced IFNγ in human and mouse whole blood with IC50 values of 2.7 and 7.0 μM, respec... | |||
T61658 | TYK2-IN-11 | ||
TYK2-IN-11 (Compound 5B) is a potent and selective inhibitor of Tyk-2, providing inhibition to TYK2-JH2 and JAK1-JH2 with IC50 values of 0.016 nM and 0.31 nM, respectively. This compound demonstrates potential for advanc... | |||
T63146 | JAK2/TYK2-IN-1 | ||
JAK2/TYK2-IN-2 is a potent and selective inhibitor of TYK2 (IC50: 9 nM) and JAK2 (IC50: 157 nM) with anti-inflammatory effects. | |||
T64265 | JAK1/TYK2-IN-3 | ||
JAK1/TYK2-IN-3 is a selective, potent, orally active dual inhibitor of TYK2 (IC50: 6 nM) and JAK1 (IC50: 37 nM).JAK1/TYK2-IN-3 selectively acts on both JAK2 and JAK3 with IC50 values of 140 nM and 362 nM.JAK1/TYK2 -IN-3 ... | |||
T75026 | PROTAC TYK2 degradation agent1 | PROTACs | |
PROTAC TYK2 Degradation Agent1 is a potent, subtype-selective degrader of TYK2, exhibiting degradation activity with a DC50 of 14 nM. It is utilized in autoimmune disease research [1]. | |||
T72421 | LRRK2/NUAK1/TYK2-IN-1 | ||
LRRK2/NUAK1/TYK2-IN-1 (compound 226) exhibits inhibitory activity against LRRK2 (Wt), LRRK2 (G2019), TYK2, and NUAK1, demonstrating IC50 values below 10 nM. This compound is useful for research into autoimmune diseases. | |||
T12266 | Ilginatinib | NS-018 | Tyrosine Kinases , JAK |
Ilginatinib (NS-018) is a highly active and orally bioavailable inhibitor of JAK2. | |||
T12266L2 | Ilginatinib hydrochloride | NS-018 hydrochloride | Tyrosine Kinases , JAK |
Ilginatinib hydrochloride (NS-018 hydrochloride) is a highly active and orally bioavailable inhibitor of JAK2. | |||
T12266L | Ilginatinib maleate | NS-018 maleate | Tyrosine Kinases , JAK |
Ilginatinib maleate (NS-018 maleate) is a highly active and orally bioavailable inhibitor of JAK2. | |||
T22338 | 2,6-Dichloro-N-(2-(cyclopropanecarboxamido)pyridin-4-yl)benzamide | GDC046 | Others , JAK |
2,6-Dichloro-N-(2-(cyclopropanecarboxamido)pyridin-4-yl)benzamide (GDC046), a potent lead analog, has good kinase selectivity, physicochemical properties and pharmacokinetic profile. | |||
T22142 | RO8191 | RO4948191,CDM-3008 | HCV Protease , HBV , JAK , IFNAR , STAT |
RO8191 (CDM-3008) (CDM-3008) is an agonist of interferon (IFN) receptor. | |||
T6104 | Cerdulatinib hydrochloride | Cerdulatinib,PRT2070,PRT062070 hydrochloride,PRT062070,PRT2070 hydrochloride | MLK , c-Fms , Tyrosine Kinases , Hippo pathway , JAK , Syk |
Cerdulatinib hydrochloride (PRT2070 hydrochloride) is an oral active, multi-targeted tyrosine kinase inhibitor with IC50 of 12 nM/6 nM/8 nM/0.5 nM and 32 nM for JAK1/JAK2/JAK3/TYK2 and Syk, respectively. Also inhibits 19... | |||
T5049 | NVP-BSK805 | NVP-BSK805 2HCl,BSK 805 | Tyrosine Kinases , JAK |
NVP-BSK805 (BSK 805) is an ATP-competitive JAK2 inhibitor. |